Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses a drug, such as HPPH, that is absorbed by tumor cells.
The drug becomes active when it is exposed to a certain kind of light. When the drug is
active, tumor cells are killed.
PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic
therapy using HPPH in treating patients with stage 0 non-small cell lung cancer.